Bridge Creek Capital Management LLC Teva Pharmaceutical Industries LTD Transaction History

Bridge Creek Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 10, 2019	SELL	$6.16 - $9.6 $187,418 - $292,080	-30,425 Closed	0 $0
Q2 2019 Jul 12, 2019	BUY	$8.12 - $15.72 $21,111 - $40,872	2,600 Added 9.34%	30,425 $281,000
Q1 2019 Apr 05, 2019	SELL	$15.58 - $20.01 $10,516 - $13,506	-675 Reduced 2.37%	27,825 $436,000
Q4 2018 Jan 18, 2019	SELL	$14.59 - $23.84 $1,459 - $2,384	-100 Reduced 0.35%	28,500 $439,000
Q3 2018 Oct 12, 2018	SELL	$21.06 - $25.65 $2,253 - $2,744	-107 Reduced 0.37%	28,600 $616,000
Q2 2018 Jul 20, 2018	BUY	$16.77 - $24.71 $304,241 - $448,288	18,142 Added 171.72%	28,707 $698,000
Q1 2018 Apr 09, 2018	SELL	$16.68 - $22.07 $306,695 - $405,801	-18,387 Reduced 63.51%	10,565 $2.69 Million
Q1 2018 Apr 09, 2018	BUY	$16.68 - $22.07 $2,085 - $2,758	125 Added 0.43%	28,952 $495,000
Q4 2017 Jan 19, 2018	SELL	$11.23 - $19.1 $122,070 - $207,617	-10,870 Reduced 27.38%	28,827 $0
Q3 2017 Oct 12, 2017	BUY	$15.41 - $32.17 $611,730 - $1.28 Million	39,697	39,697 $699,000

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Bridge Creek Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bridge Creek Capital Management LLC with notifications on news.